InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
5
T+90 胜率
100%
T+90 平均收益
+8.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Fromkin Andrew J., Director. Director active across 1 company, notably Immunovant, Inc.. Cumulatively, 16 disclosures have been published. Breakdown: 1 buy · 5 sells. Total volume traded: €7.1m. History available since 10 August 2021. The latest transaction was filed on 28 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Fromkin Andrew J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
31,668 股@ US$4.990.0024% mcap1.5% 占其流量Common StockSEC:0001341896-26-000004:0
71,492 股@ US$7.940.0087% mcap5.5% 占其流量Common StockSEC:0001341896-26-000004:1
77,181 股@ US$8.430.010% mcap6.3% 占其流量Common StockSEC:0001341896-26-000004:2
16,260 股@ US$14.700.0037% mcap2.3% 占其流量Common StockSEC:0001341896-26-000004:3
11,483 股@ US$32.640.0058% mcap3.6% 占其流量Common StockSEC:0001341896-26-000004:4
210,468 股@ US$33.560.11% mcap68.3% 占其流量Common StockSEC:0001341896-26-000004:5
13,880 股0Common StockSEC:0001764013-26-000050:0
19,351 股@ US$23.140.0069% mcap45.6% 占其流量Common StockSEC:0001764013-25-000160:0
16,188 股0Common StockSEC:0001764013-25-000043:0
6,616 股@ US$19.521.3% 占其流量Common StockSEC:0001764013-25-000034:0
11,255 股0Common StockSEC:0001764013-24-000067:0
3,941 股@ US$38.781.6% 占其流量Common StockSEC:0001764013-23-000156:0
12,523 股0Common StockSEC:0001764013-23-000045:0
21,059 股0Common StockSEC:0001764013-22-000097:0
21,726 股0Common StockSEC:0001764013-22-000021:0
5,500 股@ US$7.900.4% 占其流量Common StockSEC:0001764013-21-000081:0
标准退出：2021年11月8日 (T+90)
16 条申报中的 16 条
About Fromkin Andrew J.
Andrew J. Fromkin is a Director at Immunovant, Inc. As a board member, he contributes to the governance of the company, providing his expertise and strategic advice. His role is essential in guiding Immunovant's decisions and initiatives.
